Mike Hennessy Sr, chairman & founder

As treatments for lung cancer move forward and patient care services continue to expand, the role of the pharmacist in oncology is critical.

We’re focusing on hematologic cancer news this month, while also keeping coronavirus disease 2019 (COVID-19) at the forefront of oncology pharmacy.

The annual NASP conference has become a can’t-miss event for specialty stakeholders to stay abreast of rapid developments in the field, offering opportunities to meet with key opinion leaders.

With the outbreak of COVID-19, pharmacists throughout the world are called not just to dispense medications but also, importantly, to be a source of critical information and support for the public.